AbbVie To Rally Over 22%? Here Are 10 Top Analyst Forecasts For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. • Barclays increased AbbVie Inc. price target from $160 to $170. Barclays analyst Carter Gould upgraded the…
#abbvieinc #cartergould #equalweight #abbvie #jpmorgan #olincorporation #morgan #jeffreyzekauskas #overweight #olin